Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
Public ClinicalTrials.gov record NCT03201757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder
Study identification
- NCT ID
- NCT03201757
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 523 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 16 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2017 (Actual)
- Primary completion
- Sep 6, 2023 (Actual)
- Completion
- Sep 6, 2023 (Actual)
- Last update posted
- Sep 26, 2024
2017 – 2023
United States locations
- U.S. sites
- 49
- U.S. states
- 15
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Little Rock | Arkansas | 72211 | — |
| Alkermes Investigational Site | Rogers | Arkansas | 72758 | — |
| Alkermes Investigational Site | Anaheim | California | 92805 | — |
| Alkermes Investigational Site | Cerritos | California | 90703 | — |
| Alkermes Investigational Site | Culver City | California | 90230 | — |
| Alkermes Investigational Site | Garden Grove | California | 92845 | — |
| Alkermes Investigational Site | Glendale | California | 91206 | — |
| Alkermes Investigational Site | Long Beach | California | 90822 | — |
| Alkermes Investigational Site | Oakland | California | 94607 | — |
| Alkermes Investigational Site | Oceanside | California | 92056 | — |
| Alkermes Investigational Site | Orange | California | 92868 | — |
| Alkermes Investigational Site | Palo Alto | California | 94305 | — |
| Alkermes Investigational Site | Pico Rivera | California | 90660 | — |
| Alkermes Investigational Site | Redlands | California | 92374 | — |
| Alkermes Investigational Site | San Diego | California | 92013 | — |
| Alkermes Investigational Site | Temecula | California | 92591 | — |
| Alkermes Investigational Site | Torrance | California | 90502 | — |
| Alkermes Investigational Site | Lauderhill | Florida | 33319 | — |
| Alkermes Investigational Site | North Miami | Florida | 33161 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30303 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30329 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30331 | — |
| Alkermes Investigational Site | Augusta | Georgia | 30912 | — |
| Alkermes Investigational Site | Decatur | Georgia | 30030 | — |
| Alkermes Investigational Site | Chicago | Illinois | 60611 | — |
| Alkermes Investigational Site | Chicago | Illinois | 60640 | — |
| Alkermes Investigational Site | Winfield | Illinois | 60190 | — |
| Alkermes Investigational Site | Grand Rapids | Michigan | 49503 | — |
| Alkermes Investigational Site | Flowood | Mississippi | 39232 | — |
| Alkermes Investigational Site | Kansas City | Missouri | 64108 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63110 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63118 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63128 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63141 | — |
| Alkermes Investigational Site | Las Vegas | Nevada | 89102 | — |
| Alkermes Investigational Site | Berlin | New Jersey | 08009 | — |
| Alkermes Investigational Site | Marlton | New Jersey | 08053 | — |
| Alkermes Investigational Site | Brooklyn | New York | 11235 | — |
| Alkermes Investigational Site | Rochester | New York | 14615 | — |
| Alkermes Investigational Site | Canton | Ohio | 44718 | — |
| Alkermes Investigational Site | Cincinnati | Ohio | 45219 | — |
| Alkermes Investigational Site | Dayton | Ohio | 45417 | — |
| Alkermes Investigational Site | Eugene | Oregon | 97401 | — |
| Alkermes Investigational Site | Austin | Texas | 78759 | — |
| Alkermes Investigational Site | DeSoto | Texas | 75115 | — |
| Alkermes Investigational Site | Fort Worth | Texas | 76104 | — |
| Alkermes Investigational Site | Houston | Texas | 77030 | — |
| Alkermes Investigational Site | Richardson | Texas | 75080 | — |
| Alkermes Investigational Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03201757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 26, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03201757 live on ClinicalTrials.gov.